-
Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
Boekel, L. & Wolbink, G. J., 1 Mar 2022, In: The Lancet Rheumatology. 4, 3, p. e154-e155Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications